These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 15259907)

  • 1. Destabilization of the non-pathogenic, cellular prion-protein by a small molecular drug.
    Ochel HJ; Gademann G
    Antivir Ther; 2004 Jun; 9(3):441-5. PubMed ID: 15259907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hsp90 inhibitors identified from a library of novobiocin analogues.
    Yu XM; Shen G; Neckers L; Blake H; Holzbeierlein J; Cronk B; Blagg BS
    J Am Chem Soc; 2005 Sep; 127(37):12778-9. PubMed ID: 16159253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hsp90 functions to balance the phosphorylation state of Akt during C2C12 myoblast differentiation.
    Yun BG; Matts RL
    Cell Signal; 2005 Dec; 17(12):1477-85. PubMed ID: 15935620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.
    Marcu MG; Schulte TW; Neckers L
    J Natl Cancer Inst; 2000 Feb; 92(3):242-8. PubMed ID: 10655441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of prion protein structural integrity by geldanamycin.
    Ochel HJ; Gademann G; Trepel J; Neckers L
    Glycobiology; 2003 Sep; 13(9):655-60. PubMed ID: 12773477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis and biological activity of simplified denoviose-coumarins related to novobiocin as potent inhibitors of heat-shock protein 90 (hsp90).
    Radanyi C; Le Bras G; Messaoudi S; Bouclier C; Peyrat JF; Brion JD; Marsaud V; Renoir JM; Alami M
    Bioorg Med Chem Lett; 2008 Apr; 18(7):2495-8. PubMed ID: 18304811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Hsp90 inhibition for induction of apoptosis and inhibition of growth in cervical carcinoma cells in vitro and in vivo.
    Schwock J; Pham NA; Cao MP; Hedley DW
    Cancer Chemother Pharmacol; 2008 Apr; 61(4):669-81. PubMed ID: 17579866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transactivation of hsp70-1/2 in geldanamycin-treated human non-small cell lung cancer H460 cells: involvement of intracellular calcium and protein kinase C.
    Shu CW; Cheng NL; Chang WM; Tseng TL; Lai YK
    J Cell Biochem; 2005 Apr; 94(6):1199-209. PubMed ID: 15696546
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of the hypoxia-inducible factor system by low levels of heat shock protein 90 inhibitors.
    Ibrahim NO; Hahn T; Franke C; Stiehl DP; Wirthner R; Wenger RH; Katschinski DM
    Cancer Res; 2005 Dec; 65(23):11094-100. PubMed ID: 16322259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of hypoxia-inducible factor-1alpha accumulation and cell cycle in geldanamycin-treated human cervical carcinoma cells by laser scanning cytometry.
    Schwock J; Geddie WR; Hedley DW
    Cytometry A; 2005 Dec; 68(2):59-70. PubMed ID: 16228978
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heat-shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin suppresses glial inflammatory responses and ameliorates experimental autoimmune encephalomyelitis.
    Dello Russo C; Polak PE; Mercado PR; Spagnolo A; Sharp A; Murphy P; Kamal A; Burrows FJ; Fritz LC; Feinstein DL
    J Neurochem; 2006 Dec; 99(5):1351-62. PubMed ID: 17064348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Hsp90 function delays and impairs recovery from heat shock.
    Duncan RF
    FEBS J; 2005 Oct; 272(20):5244-56. PubMed ID: 16218955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Hsp90 inhibitor 17-allylamide-17-demethoxygeldanamycin induces apoptosis and differentiation of Kasumi-1 harboring the Asn822Lys KIT mutation and down-regulates KIT protein level.
    Yu W; Rao Q; Wang M; Tian Z; Lin D; Liu X; Wang J
    Leuk Res; 2006 May; 30(5):575-82. PubMed ID: 16213582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Geldanamycin activates Hsp70 response and attenuates okadaic acid-induced cytotoxicity in human retinal pigment epithelial cells.
    Kaarniranta K; Ryhänen T; Sironen RK; Suuronen T; Elo MA; Karjalainen HM; Lammi MJ; Teräsvirta M; Uusitalo H; Salminen A
    Brain Res Mol Brain Res; 2005 Jun; 137(1-2):126-31. PubMed ID: 15950770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 17-dimethylaminoethylamino-17-demethoxy-geldanamycin (17DMAG) and 17-allylamino-17-demethoxygeldanamycin (17AAG) in vitro: effects on Hsp90 and client proteins in melanoma models.
    Smith V; Sausville EA; Camalier RF; Fiebig HH; Burger AM
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):126-37. PubMed ID: 15841378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hsp90 inhibitor geldanamycin increases the sensitivity of resistant ovarian adenocarcinoma cell line A2780cis to cisplatin.
    Solár P; Horváth V; Kleban J; Koval' J; Solárová Z; Kozubík A; Fedorocko P
    Neoplasma; 2007; 54(2):127-30. PubMed ID: 17319785
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteome-wide changes induced by the Hsp90 inhibitor, geldanamycin in anaplastic large cell lymphoma cells.
    Schumacher JA; Crockett DK; Elenitoba-Johnson KS; Lim MS
    Proteomics; 2007 Aug; 7(15):2603-16. PubMed ID: 17610208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geldanamycin induces Hsp70 and prevents alpha-synuclein aggregation and toxicity in vitro.
    McLean PJ; Klucken J; Shin Y; Hyman BT
    Biochem Biophys Res Commun; 2004 Aug; 321(3):665-9. PubMed ID: 15358157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Charged bipolar suramin derivatives induce aggregation of the prion protein at the cell surface and inhibit PrPSc replication.
    Nunziante M; Kehler C; Maas E; Kassack MU; Groschup M; Schätzl HM
    J Cell Sci; 2005 Nov; 118(Pt 21):4959-73. PubMed ID: 16219680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of multiple signalling pathways by heat shock protein 90 molecular chaperone inhibitors.
    Powers MV; Workman P
    Endocr Relat Cancer; 2006 Dec; 13 Suppl 1():S125-35. PubMed ID: 17259553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.